Page 21 - Genentech News Today

The Swiss contract manufacturer’s cash deal for Roche’s Genentech facility in Vacaville, California, is one of the world’s largest manufacturing sites for biologics—a major growth driver for Lonza and other CDMOs.

According to a report by the Federal Council of Switzerland, the Swiss GDP growth is projected to remain sluggish at 1.1% in 2024, with a moderate growth of 1.7% anticipated in 2025 as the global economy...

Here’s a little business drama to go with your morning coffee.

Jennifer Coolidge, an award-winning actor known for her numerous iconic roles in film and on television, will deliver the 2024 Commencement address at Washington University in St. Louis, according to Chancellor Andrew D. Martin.

Even if patients with EGFR-mutated lung cancer progress on amivantamab plus chemotherapy, there is a survival benefit over chemotherapy alone, follow-up analyses of PAPILLON and MARIPOSA-2 showed.

Ms. Sjogren brings nearly 30 years of biopharmaceutical experience building commercial organizations and leading successful oncology launches Pending acquisition of AnHeart Therapeutics and...

AFM24 combination with atezolizumab (AFM24-102): Follow-up of the Phase 1/2a combination study confirmed four responses in the non-small cell cancer...

Nearly three months into 2024, it’s clear that the bullish trends are here to stay. Markets hit a bottom in late October, but since then the S&P 500 has gained 27% and now stands at more than 5,200. The NASDAQ index is up 30% from its own October 27 low point. These are bull-market numbers, and show little sign of stopping. Watching the market from Oppenheimer, chief investment strategist John Stoltzfus comments on the market outlook: “S&P 500 earnings results over the mo...

Both Metro and ODOT have been studying the idea of tolling on the west side for a few years. They began meeting with local officials in 2022.

Half Yearly Report - 31 December 2023 Kazia Therapeutics Limited ...